← Back to Clinical Trials
Recruiting NCT05954299

NCT05954299 Vincere Biobank Research Protocol

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05954299
Status Recruiting
Phase
Sponsor Vincere Cancer Center
Condition Cancer
Study Type OBSERVATIONAL
Enrollment 5,000 participants
Start Date 2023-07-18
Primary Completion 2033-12-31

Trial Parameters

Condition Cancer
Sponsor Vincere Cancer Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 5,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-07-18
Completion 2033-12-31

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The Vincere Biobank aims to make quality biospecimens and associated clinical data available for research studies related to advancing medicine and improving care for patients, including cancer screening, treatment, and care.

Eligibility Criteria

Inclusion Criteria: * 18 years of age or older; any gender * Able to donate a blood, urine, tissue, and/or other biospecimen sample * Able to provide informed consent to participate in the study Exclusion Criteria: * Minors, under the age of 18 years * Individuals who lack the capacity to give informed consent

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology